Clinical trials
Completed Observational Carcinoma, Transitional Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
31 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 3 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2 |
| AstraZeneca | 2 |
| British Urology Researchers in Surgical Training | 2 |
| Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2 |
| Pacific Edge Limited | 2 |
| Pfizer | 2 |
| AnchorDx Medical Co., Ltd. | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Centre Hospitalier Universitaire, Amiens | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 31 |
| Urinary Bladder Neoplasms | 10 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Carcinoma, Renal Cell | 3 |
| Carcinoma, Hepatocellular | 2 |
| Hematuria | 2 |
| Non-Muscle Invasive Bladder Neoplasms | 2 |
| Small Cell Lung Carcinoma | 2 |
| Testicular Neoplasms | 2 |
| Colorectal Neoplasms | 1 |
Trials
Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.